Status: Recruiting
A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
This is a study assessing the feasibility of performing an anti-aging intervention which is a combination of an exercise regimen, spermidine supplementation, and either rapamycin or lamivudine.
Participants needed: 22
Trial details
Phase: Phase 1Age: 65-80Biological sex: AllType: InterventionalSponsor: Icahn School of Medicine at Mount SinaiUpdated: Sep 25, 2025Locations: 1
Eligibility criteria
Patients 65-80 years old [+6]
Patients may not have cancer requiring active therapy within the last 2 years [+20]